Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OASIS: Valine vs Essential Amino Acids in Hemodialysis Patients
NCT05705414Phase 1Completed
- Sponsor
- UT Health San Antonio
- Start
- Oct 2024
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of valine and essential amino acids-University of Oregon in end stage renal disease (ESRD) (2 arms), sponsored by UT Health San Antonio. Primary endpoint: Brief Fatigue Inventory at 17 weeks. Started Oct 2024; status: completed.
02
Drugs
valineessential amino acids-University of Oregon
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT05705414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05705414.